470 related articles for article (PubMed ID: 30635936)
1. Brain and cord imaging features in neuromyelitis optica spectrum disorders.
Cacciaguerra L; Meani A; Mesaros S; Radaelli M; Palace J; Dujmovic-Basuroski I; Pagani E; Martinelli V; Matthews L; Drulovic J; Leite MI; Comi G; Filippi M; Rocca MA
Ann Neurol; 2019 Mar; 85(3):371-384. PubMed ID: 30635936
[TBL] [Abstract][Full Text] [Related]
2. Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis.
Bensi C; Marrodan M; González A; Chertcoff A; Osa Sanz E; Chaves H; Schteinschnaider A; Correale J; Farez MF
Mult Scler Relat Disord; 2018 Oct; 25():246-250. PubMed ID: 30144694
[TBL] [Abstract][Full Text] [Related]
3. MRI Features of Aquaporin-4 Antibody-Positive Longitudinally Extensive Transverse Myelitis: Insights into the Diagnosis of Neuromyelitis Optica Spectrum Disorders.
Chee CG; Park KS; Lee JW; Ahn HW; Lee E; Kang Y; Kang HS
AJNR Am J Neuroradiol; 2018 Apr; 39(4):782-787. PubMed ID: 29449281
[TBL] [Abstract][Full Text] [Related]
4. Spectrum of MRI brain lesion patterns in neuromyelitis optica spectrum disorder: a pictorial review.
Wang KY; Chetta J; Bains P; Balzer A; Lincoln J; Uribe T; Lincoln CM
Br J Radiol; 2018 Jun; 91(1086):20170690. PubMed ID: 29388807
[TBL] [Abstract][Full Text] [Related]
5. Imaging Differences between Neuromyelitis Optica Spectrum Disorders and Multiple Sclerosis: A Multi-Institutional Study in Japan.
Tatekawa H; Sakamoto S; Hori M; Kaichi Y; Kunimatsu A; Akazawa K; Miyasaka T; Oba H; Okubo T; Hasuo K; Yamada K; Taoka T; Doishita S; Shimono T; Miki Y
AJNR Am J Neuroradiol; 2018 Jul; 39(7):1239-1247. PubMed ID: 29724765
[TBL] [Abstract][Full Text] [Related]
6. Seronegative neuromyelitis optica spectrum disorder patients diagnosed using new diagnostic criteria.
Uzawa A; Mori M; Uchida T; Masuda H; Ohtani R; Kuwabara S
Mult Scler; 2016 Sep; 22(10):1371-5. PubMed ID: 26552730
[TBL] [Abstract][Full Text] [Related]
7. Clinical and MRI measures to identify non-acute MOG-antibody disease in adults.
Cortese R; Battaglini M; Prados F; Bianchi A; Haider L; Jacob A; Palace J; Messina S; Paul F; Wuerfel J; Marignier R; Durand-Dubief F; de Medeiros Rimkus C; Callegaro D; Sato DK; Filippi M; Rocca MA; Cacciaguerra L; Rovira A; Sastre-Garriga J; Arrambide G; Liu Y; Duan Y; Gasperini C; Tortorella C; Ruggieri S; Amato MP; Ulivelli M; Groppa S; Grothe M; Llufriu S; Sepulveda M; Lukas C; Bellenberg B; Schneider R; Sowa P; Celius EG; Proebstel AK; Yaldizli Ö; Müller J; Stankoff B; Bodini B; Carmisciano L; Sormani MP; Barkhof F; De Stefano N; Ciccarelli O;
Brain; 2023 Jun; 146(6):2489-2501. PubMed ID: 36515653
[TBL] [Abstract][Full Text] [Related]
8. Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis.
Jurynczyk M; Geraldes R; Probert F; Woodhall MR; Waters P; Tackley G; DeLuca G; Chandratre S; Leite MI; Vincent A; Palace J
Brain; 2017 Mar; 140(3):617-627. PubMed ID: 28364548
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of brain and spinal cord lesion distribution criteria at disease onset in distinguishing NMOSD from MS and MOG antibody-associated disorder.
Cai MT; Zheng Y; Shen CH; Yang F; Fang W; Zhang YX; Ding MP
Mult Scler; 2021 May; 27(6):871-882. PubMed ID: 32672091
[TBL] [Abstract][Full Text] [Related]
10. Whole spinal transverse myelitis in neuromyelitis optica spectrum disorder.
Etemadifar M; Mousavi S; Salari M; Hosseinian SA; Mansouri AR
Mult Scler Relat Disord; 2024 Jul; 87():105666. PubMed ID: 38749352
[TBL] [Abstract][Full Text] [Related]
11. Short transverse myelitis in Chinese patients with neuromyelitis optica spectrum disorders.
Hu H; You X; Ye J
Mult Scler Relat Disord; 2018 Apr; 21():78-83. PubMed ID: 29499441
[TBL] [Abstract][Full Text] [Related]
12. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B;
J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206
[TBL] [Abstract][Full Text] [Related]
13. Quantitative spinal cord MRI in MOG-antibody disease, neuromyelitis optica and multiple sclerosis.
Mariano R; Messina S; Roca-Fernandez A; Leite MI; Kong Y; Palace JA
Brain; 2021 Feb; 144(1):198-212. PubMed ID: 33206944
[TBL] [Abstract][Full Text] [Related]
14. Comparison of brain and spinal cord magnetic resonance imaging features in neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody.
Fan M; Fu Y; Su L; Shen Y; Wood K; Yang L; Liu Y; Shi FD
Mult Scler Relat Disord; 2017 Apr; 13():58-66. PubMed ID: 28427704
[TBL] [Abstract][Full Text] [Related]
15. Brain and spinal MRI features distinguishing MS from different AQP4 antibody serostatus NMOSD at disease onset in a cohort of Latin American patients.
Carnero Contentti E; Marques VD; Soto de Castillo I; Tkachuk V; Barreira AA; Caride A; Castillo MC; Cristiano E; de Aquino Cruz C; Braga Diégues Serva G; Santos ACD; Labarca R; Lavigne Moreira C; López PA; Miguez J; Molina O; Pettinicchi JP; Rojas JI
Mult Scler; 2020 Jul; 26(8):945-954. PubMed ID: 31124748
[TBL] [Abstract][Full Text] [Related]
16. Validation of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorders in a cohort of South Indian patients.
Kanikannan MA; Arepareddy PK; Mathukumalli NL; Y S; Kandadai RM; Jabeen AS; T S; Borgohain R
Mult Scler Relat Disord; 2019 Oct; 35():164-169. PubMed ID: 31382202
[TBL] [Abstract][Full Text] [Related]
17. Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging.
Pekcevik Y; Mitchell CH; Mealy MA; Orman G; Lee IH; Newsome SD; Thompson CB; Pardo CA; Calabresi PA; Levy M; Izbudak I
Mult Scler; 2016 Mar; 22(3):302-11. PubMed ID: 26209588
[TBL] [Abstract][Full Text] [Related]
18. Short segment myelitis as a first manifestation of neuromyelitis optica spectrum disorders.
Huh SY; Kim SH; Hyun JW; Jeong IH; Park MS; Lee SH; Kim HJ
Mult Scler; 2017 Mar; 23(3):413-419. PubMed ID: 28067584
[TBL] [Abstract][Full Text] [Related]
19. Quantitative 7T MRI does not detect occult brain damage in neuromyelitis optica.
Pasquier B; Borisow N; Rasche L; Bellmann-Strobl J; Ruprecht K; Niendorf T; Derfuss TJ; Wuerfel J; Paul F; Sinnecker T
Neurol Neuroimmunol Neuroinflamm; 2019 May; 6(3):e541. PubMed ID: 30882018
[TBL] [Abstract][Full Text] [Related]
20. Occurrence of Asymptomatic Acute Neuromyelitis Optica Spectrum Disorder-Typical Brain Lesions during an Attack of Optic Neuritis or Myelitis.
Kim SH; Hyun JW; Joung A; Lee SH; Kim HJ
PLoS One; 2016; 11(12):e0167783. PubMed ID: 27936193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]